Health Matters
Calls for Drug Company Nationalisation After Adcock Job Cuts

Calls for Drug Company Nationalisation After Adcock Job Cuts

Explore the calls for drug company nationalisation in South Africa amid rising job cuts and concerns in the pharmaceutical industry. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...

Excessive Dialysis Product Pricing: Adcock Ingram Referred

The excessive Dialysis Product Pricing case targets Adcock Ingram, with a possible 10% turnover penalty and wider renal care cost impacts. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...

Local Pharmaceutical Manufacturing for Future Sustainability

South Africa’s local drug makers are pressing the National Department of Health to change course on upcoming procurement. The issue of local pharmaceutical manufacturing is at the heart of their concerns. Pharmaceuticals Made in South Africa (Pharmisa) says domestic...

Adcock Ingram Delisting After Natco Acquisition

Adcock Ingram delisting from the JSE is confirmed for November 11. Learn about the impact of the Natco Pharma acquisition. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...

Adcock Ingram Takeover Gets Green Light from Shareholders

Shareholders have approved the Adcock Ingram takeover by Natco Pharma, marking a new chapter for the pharmaceutical company. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...